Cyclophosphamide trials for Rheumatoid arthritis

All Cyclophosphamide trials · All Rheumatoid arthritis trials

Phase breakdown

Recruiting trials studying Cyclophosphamide for Rheumatoid arthritis

• A Phase 1 Study of ADI-001 in Rheumatoid Arthritis
  NCT07100873 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
  NCT06733935 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 18 locations
• A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
  NCT07115745 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 28 locations
• Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
  NCT06581562 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Cyclophosphamide for Rheumatoid arthritis?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.